Teriflunomide for relapsing remitting multiple sclerosis

Teriflunomide (Aubagio) is licensed for the treatment of adults with RRMS. Here, Steve Chaplin presents the clinical data relating to its efficacy and Dr Schmierer discusses its place in therapy.

Teriflunomide for relapsing remitting multiple sclerosis

Add yours ↓
Web design and marketing agency Leamington Spa